Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Revue Medicale De Bruxelles|October 28, 2008
[Practical approach to hypereosinophilia]F Roufosse, E CoganAllergy|June 8, 2004
Recent advances in pathogenesis and management of hypereosinophilic syndromesF Roufosse, E Cogan, M GoldmanLa Revue Du Praticien|May 16, 2000
[Chronic hypereosinophilia: a model of Th2 disorders]F Roufosse, L Schandené, E Cogan, et al.Revue Medicale De Bruxelles|February 15, 2003
[The general internal medicine department]E Cogan, G Decaux, P Neve, et al.Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
The idiopathic hypereosinophilic syndrome: clinical presentation, pathogenesis and therapeutic strategiesF Roufosse, E Bartholomé, L Schandené, et al.Postgraduate Medical Journal|June 9, 1998
Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotideJ Matte, F Roufosse, P Rocmans, et al.European Journal of Immunology|April 12, 2001
Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivoA de Lavareille, F Roufosse, L Schandené, et al.Blood|July 27, 1999
T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophiliaF Roufosse, L Schandené, C Sibille, et al.Blood|December 9, 2000
Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophiliaL Schandené, F Roufosse, A de Lavareille, et al.Clinical and Experimental Rheumatology|June 10, 2006
Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patientsF Vandergheynst, A Ocmant, C Sordet, et al.Pageof 2